Dr Mo Yin
Infectious Diseases Physician
Bacterial Resistance Analysis Group
Dr Mo Yin is a highly motivated Infectious Diseases physician driven by the ideal of using quality clinical research to influence patient care and propel health policies. She has been active in epidemiological and clinical research, medical education, as well as hospital administration. She has received numerous awards for her achievements in clinical care, research and teaching.
Currently she is pursuing a PhD, where she is leading a multi-centre randomised control trial to assess the impact of shortening treatment duration for ventilator-associated pneumoniae.
Dr Mo Yin’s career goal is to serve her community focusing on translational research to influence regional and global policies.
Next generation sequencing identifies multi-drug resistant herpes simplex virus- associated scrotal ulceration.
Mo Y. et al, (2020), The Journal of infection, 80, 232 - 254
Optimising trial designs to identify appropriate antibiotic treatment durations
Pouwels KB. et al, (2019), BMC Medicine, 17
Assessing non-adherence in non-inferiority trials: implications from a simulation study
Mo Y. et al, (2019), TRIALS, 20
The socio-economic impact of multidrug-resistant nosocomial infections: a qualitative study.
Mo Y. et al, (2019), The Journal of hospital infection, 102, 454 - 460
Relating knowledge, attitude and practice of antibiotic use to extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage: results of a cross-sectional community survey.
Mo Y. et al, (2019), BMJ open, 9